Comparing Efficacy & Safety Of TNX-1300 To Placebo With UC For Treatment Of Acute Cocaine Intoxication In ED Subjects (CATALYST)

计划入组 3 人 · 首次发布于 2023 年 9 月 21 日

An Open-Label, Randomized Pilot Study Comparing the Safety of a Single Dose of TNX-1300 to Usual Care (UC) Alone for the Treatment of Signs and Symptoms of Acute Cocaine Intoxication in Male Emergency Department (ED) Subjects

首次发布于 2021 年 8 月 9 日

Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)

计划入组 99 人 · 首次发布于 2024 年 2 月 14 日

Cocaine(Goprelto, Numbrino)

C₁₇H₂₁NO₄

Ery-CoCe

Cocaine abuse vaccine TA-CD

COCHIN HOSPITAL

India

Corline Biomedical AB

Sweden

Tonix Pharmaceuticals Advocates for PGIC as Primary Endpoint in Long COVID Trials

Tonix Pharmaceuticals Bolsters Leadership as TNX-102 SL Awaits FDA Decision for Fibromyalgia

Experimental Medication Shows Promise in Treating Cocaine Addiction